PubMed:22427674
Annnotations
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 120-127 | Cell | denotes | epsilon | http://purl.obolibrary.org/obo/CL:0003025 |
| T2 | 455-474 | Cell | denotes | hippocampal neurons | http://purl.obolibrary.org/obo/CL:0002608 |
| T3 | 916-924 | Cell | denotes | neuronal | http://purl.obolibrary.org/obo/CL:0000540 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-128 | Sentence | denotes | Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon. |
| T2 | 129-289 | Sentence | denotes | Synaptic loss is the earliest pathological change in Alzheimer disease (AD) and is the pathological change most directly correlated with the degree of dementia. |
| T3 | 290-395 | Sentence | denotes | ApoE4 is the major genetic risk factor for the age-dependent form of AD, which accounts for 95% of cases. |
| T4 | 396-597 | Sentence | denotes | Here we show that in synaptic networks formed from primary hippocampal neurons in culture, apoE3, but not apoE4, prevents the loss of synaptic networks produced by amyloid β oligomers (amylospheroids). |
| T5 | 598-876 | Sentence | denotes | Specific activators of PKCε, such as 8-(2-(2-pentyl-cyclopropylmethyl)-cyclopropyl)-octanoic acid methyl ester and bryostatin 1, protected against synaptic loss by amylospheroids, whereas PKCε inhibitors blocked this synaptic protection and also blocked the protection by apoE3. |
| T6 | 877-971 | Sentence | denotes | Blocking LRP1, an apoE receptor on the neuronal membrane, also blocked the protection by apoE. |
| T7 | 972-1064 | Sentence | denotes | ApoE3, but not apoE4, induced the synthesis of PKCε mRNA and expression of the PKCε protein. |
| T8 | 1065-1155 | Sentence | denotes | Amyloid β specifically blocked the expression of PKCε but had no effect on other isoforms. |
| T9 | 1156-1274 | Sentence | denotes | These results suggest that protection against synaptic loss by apoE is mediated by a novel intracellular PKCε pathway. |
| T10 | 1275-1397 | Sentence | denotes | This apoE pathway may account for much of the protective effect of apoE and reduced risk for the age-dependent form of AD. |
| T11 | 1398-1482 | Sentence | denotes | This finding supports the potential efficacy of newly developed therapeutics for AD. |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 182-199 | HP_0002511 | denotes | Alzheimer disease |
| T2 | 280-288 | HP_0000726 | denotes | dementia |
| T3 | 560-567 | HP_0011034 | denotes | amyloid |
| T4 | 1065-1072 | HP_0011034 | denotes | Amyloid |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_22427674_0_0 | 0-17 | expanded | denotes | Apolipoprotein E3 |
| SS2_22427674_0_0 | 19-24 | abbr | denotes | ApoE3 |
| SS1_22427674_1_0 | 182-199 | expanded | denotes | Alzheimer disease |
| SS2_22427674_1_0 | 201-203 | abbr | denotes | AD |
| AE1_22427674_0_0 | SS1_22427674_0_0 | SS2_22427674_0_0 | abbreviatedTo | Apolipoprotein E3,ApoE3 |
| AE1_22427674_1_0 | SS1_22427674_1_0 | SS2_22427674_1_0 | abbreviatedTo | Alzheimer disease,AD |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 22427674-2#0#5#gene348 | 290-295 | gene348 | denotes | ApoE4 |
| 22427674-2#69#71#diseaseC0002395 | 359-361 | diseaseC0002395 | denotes | AD |
| 0#5#gene34869#71#diseaseC0002395 | 22427674-2#0#5#gene348 | 22427674-2#69#71#diseaseC0002395 | associated_with | ApoE4,AD |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 182-199 | Disease | denotes | Alzheimer disease | http://purl.obolibrary.org/obo/MONDO_0004975 |
| T2 | 201-203 | Disease | denotes | AD | http://purl.obolibrary.org/obo/MONDO_0004975 |
| T3 | 280-288 | Disease | denotes | dementia | http://purl.obolibrary.org/obo/MONDO_0001627 |
| T4 | 359-361 | Disease | denotes | AD | http://purl.obolibrary.org/obo/MONDO_0004975 |
| T5 | 560-567 | Disease | denotes | amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T6 | 1065-1072 | Disease | denotes | Amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T7 | 1394-1396 | Disease | denotes | AD | http://purl.obolibrary.org/obo/MONDO_0004975 |
| T8 | 1479-1481 | Disease | denotes | AD | http://purl.obolibrary.org/obo/MONDO_0004975 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 182-199 | Phenotype | denotes | Alzheimer disease | HP:0002511 |
| T2 | 201-203 | Phenotype | denotes | AD | HP:0002511 |
| T3 | 280-288 | Phenotype | denotes | dementia | HP:0000726 |
| T4 | 359-361 | Phenotype | denotes | AD | HP:0002511 |
| T5 | 1394-1396 | Phenotype | denotes | AD | HP:0002511 |
| T6 | 1479-1481 | Phenotype | denotes | AD | HP:0002511 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 455-474 | Body_part | denotes | hippocampal neurons | http://purl.obolibrary.org/obo/CL_0002608 |
| T2 | 925-933 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
| T5 | 1247-1260 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |